Welcome to Nivagen Pharmaceuticals
Nivagen is engaged in the development, acquisition and sales of generic prescription drugs and over the counter products for the North American market. Our vision is to deliver high quality products at affordable prices by leveraging global partnerships with the best FDA approved manufacturing facilities across the world.
Acquisition and Licensing Model
The US generic market is large and growing. The market is complex and fragmented and requires a variety of infrastructures to reach all major channels and segments
Every business has its individual core strengths. One of Nivagen’s core strengths is the ability of our sales team to launch new generic products in the US market.
Product Development / Co-Development Model
Nivagen's business model is to identify and utilize the world`s best and economical CROs and CRAMs to develop and manufacture niche generic and OTC products.
Come Meet With Us
Nivagen will be at the following events in 2023-2024:
CPhI North America 2023 – April 25-27, in Philadelphia, Pennsylvania
HDA Business and Leadership Conference 2023- June 11-14, in Colorado Springs, Colorado
NACDS Total Store Expo 2023 – August 12-14, in San Diego, California
CPhI Worldwide 2023 – October 24-26, in Barcelona, Spain
ECRM Retail Pharmacy – Generic Rx 2024
DCAT Week 2024– March 18-21, in New York City, New York